Shizuoka, Japan

Hirokazu Kawasaki

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirokazu Kawasaki. Retrieved from https://idiyas.com/inventor/hirokazu-kawasaki-jrsrhl0q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hirokazu Kawasaki: Innovator in Endometriosis Treatment

Introduction

Hirokazu Kawasaki is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of medical therapeutics, particularly in the treatment of endometriosis. His innovative approach has led to the development of a unique therapeutic agent that addresses this challenging condition.

Latest Patents

Kawasaki holds a patent for a remedy for endometriosis. The invention provides a therapeutic agent comprising an interleukin-5 antagonist as an active ingredient. This advancement represents a promising step forward in the management of endometriosis, offering hope to many affected individuals.

Career Highlights

Kawasaki is associated with Kyowa Hakko Kirin Co., Limited, a company known for its commitment to innovative healthcare solutions. His work at the company has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Kawasaki has collaborated with esteemed colleagues, including Etsuo Ohshima and Naoya Kimoto. Their combined expertise has contributed to the successful development of Kawasaki's patent and further innovations in the field.

Conclusion

Hirokazu Kawasaki's contributions to the treatment of endometriosis highlight his role as a key innovator in the medical field. His work continues to inspire advancements in therapeutic solutions for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…